Featured

Repros Therapeutics Gains 4%

Shares of Repros Therapeutics were up over 4% Monday morning after the company said the U.S. Food and Drug Administration granted an “end of phase 2” meeting to discuss the phase 3 requirements to study Proellex to treat uterine fibroids. The meeting is scheduled to occur before the end ofRead More

Ford Launches SmartLink Upgrade for Older Vehicles

Ford Motor Company said Friday that it will make connectivity features, normally only available on new modem-equipped vehicles, available to customers who own 2010-2016 model year Ford and Lincoln vehicles. By plugging in a new Ford SmartLink device to the OBD II port below the steering wheel, Ford says theseRead More

Leidos Awarded U.S. Air Force Contract

Leidos Holdings was awarded a ten-year $350 million contract by the U.S. Air Force to continue providing mission planning systems engineering and integration for the Joint Missing Planning Enterprise. Under the systems engineering and integration contract (SEIC), Leidos will continue to provide Joint Mission Planning System architecture design, program management,Read More

Vonage Holdings Issued Thirteen New Patents

Vonage Holdings was recently granted 13 new patents from the U.S. Patent and Trademark Office bringing the total patents issued in 2016 to a company record of 40. As of the end of 2016, the company held a total of 146 U.S. patents, and 200 patents still pending. Among theRead More

Infinity Pharmaceuticals Up 9%

Infinity Pharmaceuticals is up almost 9% after the company said it presented preclinical data for IPI-549, an oral immuno-oncology development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma), that showed IPI-549 is able to help overcome resistance to checkpoint inhibition. IPI-549 remodels the immune-suppressive tumor microenvironment primarily through its effects on myeloidRead More

IHS Markit Tops Estimates

IHS Markit, an information and analytics provider, reported Q4 adjusted EPS of $0.48, up from $0.44 in the same period a year ago and topping the estimate of $0.46 from analysts polled by CapIQ. Total revenues in the quarter ended Nov. 30 were $873.8 million, up from $555.7 million inRead More